T3+ and T4 Rectal Cancer Patients Seem to Benefit From the Addition of Oxaliplatin to the Neoadjuvant Chemoradiation Regimen
Titel:
T3+ and T4 Rectal Cancer Patients Seem to Benefit From the Addition of Oxaliplatin to the Neoadjuvant Chemoradiation Regimen
Auteur:
Martijnse, Ingrid S. Dudink, Ralph L. Kusters, Miranda Vermeer, Thomas A. West, Nicholas P. Nieuwenhuijzen, Grard A. Lijnschoten, Ineke van Martijn, Hendrik Creemers, Geert-Jan Lemmens, Valery E. Velde, Cornelis J. van de Sebag-Montefiore, David Glynne-Jones, Robert Quirke, Phil Rutten, Harm J.